Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Abbott Laboratories (NYSE: ABT) | Delayed: 103.70 +1.19 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.51 | 52 Week High | $46.38 | |||
| Open | $102.28 | 52 Week Low | $36.00 | |||
| Day High | $104.00 | P/E | 69.13 | |||
| Day Low | $101.56 | EPS | $1.50 | |||
| Volume | 10,279,641 | |||||
